0001209191-14-032368.txt : 20140508
0001209191-14-032368.hdr.sgml : 20140508
20140508175747
ACCESSION NUMBER: 0001209191-14-032368
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140507
FILED AS OF DATE: 20140508
DATE AS OF CHANGE: 20140508
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aldeyra Therapeutics, Inc.
CENTRAL INDEX KEY: 0001341235
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 617-513-9882
MAIL ADDRESS:
STREET 1: 15 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
FORMER COMPANY:
FORMER CONFORMED NAME: Aldexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20130102
FORMER COMPANY:
FORMER CONFORMED NAME: Neuron Systems Inc
DATE OF NAME CHANGE: 20051012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brady Todd C
CENTRAL INDEX KEY: 0001579179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36332
FILM NUMBER: 14826381
MAIL ADDRESS:
STREET 1: C/O EVOKE PHARMA, INC.
STREET 2: 12555 HIGH BLUFF DR SUITE 385
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-05-07
0
0001341235
Aldeyra Therapeutics, Inc.
ALDX
0001579179
Brady Todd C
C/O ALDEYRA THERAPEUTICS, INC.
15 NEW ENGLAND EXECUTIVE PARK
BURLINGTON
MA
01803
1
1
0
0
President and CEO
Common Stock
2014-05-07
4
P
0
12500
8.00
A
15089
D
Employee Stock Option (Right to Buy)
8.00
2014-05-07
4
A
0
76068
0.00
A
2024-05-06
Common Stock
76068
76068
D
Exercisable in equal annual installments over three years of continuous service after May 7, 2014.
/s/ Todd Brady
2014-05-08